Assessment of the Knowledge and Risk Factors Associated with Frequent Lassa Fever Outbreaks in Two Endemic Regions in South-South Nigeria doi.org/10.26538/tjnpr/v4i7.7
Main Article Content
Abstract
Frequent outbreaks of the Lassa virus had been reported weekly in Nigeria in recent months by the Nigerian Centre for Disease Control, where 23 of the 36 states in the country recorded confirmed cases in 2019 with a fatality of 20.6%. The present research assesses the knowledge and risk factors associated with continuous outbreaks of Lassa fever in Nigeria using the inhabitants of some endemic communities in Edo state as a case study. The research was conducted using a 25-item self-administered semi-structured questionnaire to elicit responses from individuals in some Lassa fever endemic communities on basic information about the biology, epidemiology, prevention and control of the disease. Data analysis was done using the Statistical Package for Social Sciences (SPSS) Version 23.0. Overall, 122 (43.7%) of the 279 participants had good knowledge of the Lassa virus, 78 (28.0%) had fair knowledge while 79 (28.3%) had poor knowledge. Furthermore, 148 (53.0%) of the respondents knew that Lassa fever is caused by a virus while 260 (93.2%) knew that rats are the vector for the virus. Only 72 (25.8%) of participants knew the effective methods of food storage to avoid vector contact and contamination with the virus. Survey showed that there is still a dearth of knowledge and awareness of the risk factors associated with frequent outbreaks of the Lassa virus in endemic communities. There is need to intensify efforts on public health education and community mobilization to curtail future outbreaks of the disease.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Frame JD, Baldwin JM, Jr, Gocke DJ Troup JM. Lassa fever, a new virus disease of man from West Africa. 1. Clinical description and pathological findings. Am J Trop Med Hyg. 1970; 19:670-676.
Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, Bajani MD, Peters CJ, Nichol ST. Genetic diversity among Lassa virus strains. J Virol. 2000; 74:6992– 7004.
Buckley SM and Casals J. Lassa fever, a new virus disease of man from West Africa. Isolation and characterization of the virus. Am J Trop Med Hyg. 1970; 19:680-691.
Hallam HJ, Hallam S, Rodriguez SE, Barrett ADT, Beasley DWC, Chua A, Ksiazek TG, Milligan GN, Sathiyamoorthy V, Reece LM. Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development. NPJ Vaccines. 2018; 20:3-11.
Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, Levy DC, Yenni RE, Moses LM, Fullah M, Momoh M, Fonnie M, Fonnie R, Kanneh L, Koroma VJ, Kargbo K, Ottomassathien D, Muncy IJ, Jones AB, Illick MM, Kulakosky PC, Haislip AM, Bishop CM, Elliot DH, Brown BL, Zhu H, Hastie KM, Andersen KG, Gire SK, Tabrizi S, Tariyal R, Stremlau M, Matschiner A, Sampey DB, Spence JS, Cross RW, Geisbert JB, Folarin OA, Happi CT, Pitts KR, Geske FJ, Geisbert TW, Saphire EO, Robinson JE, Wilson RB, Sabeti PC, Henderson LA, Khan SH, Bausch DG, Branco LM,
Garry RF. Viral Hemorrhagic Fever Consortium. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis. 2014; 8:e2748.
Bausch DG, Demby AH, Coulibaly M, Kanu J, Goba A, Bah A, Conde N, Wurtzel HL, Cavallaro KF, Lloyd E, Baldet FB, Cisse SD, Fofona D, Savane IK, Tolno RT, Mahy B, Wagoner KD, Ksiazek TG, Peters CJ, Rollin PE. Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vec Borne Zoo Dis. 2001; 1:269
– 281.
Kernéis, S, Koivogui L, Magassouba N, Koulemou K, Lewis R, Aplogan A, Grais RF, Guerin PJ, Fichet-Calvet E. Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: across-sectional study. PLoS Negl Trop Dis. 2009; 3:e548.
Safronetz D, Lopez JE, Sogoba N, Traore SF, Raffel SJ, Fischer ER, Ebihara H, Branco L, Garry RF, Schwan TG, Feldmann H. Detection of Lassa virus, Mali. Emerg Infect Dis. 2010; 16:1123–1126.
Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, Pinneo L, Gary GW, Kissling RE. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg. 1973; 22:773–779.
Monson MH, Frame JD, Jahrling PB, Alexander K. Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia. Trans R Soc Trop Med Hyg. 1984; 78:549– 553.
Fichet-Calvet E and Rogers DJ. Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis. 2009; 3:e388.
Ehichioya DU, Hass M, Olschlager S, Becker-Ziaya B., Chukwu, COO., Coker J, Nasidi A, Ogugua OO, Gunther S. Omilabu SA. Lassa fever, Nigeria, 2005-2008. Emerg Infect Dis. 2010; 16(6):1040-1041.
Elsie AI, Yuki F, Oladipupo BI, Dan-Nwafor CC, Anwar A, Oboma EW, Ephraim O, Sylvanus O, Uche U, Emeka O, Olufemi A, Chukwuyem A, Ahmed AL, Emmanuel OM, Solomon FW, Clement LP, Alemu W, Chikwe I. Epidemiology and clinical features of Lassa fever outbreak in Nigeria. Emerg Infect Dis. 2019; 25(6): 1066-1074.
Nigerian Centre for Disease Control (NCDC 2020) Lassa fever situation report Epi Week 18: 26th April-03rd May 2020. Available from: https://ncdc.gov.ng/themes/common/files/sitreps/8d609130c 4f8dbe6754d32767795c5d7.pdf. [cited 2020 May 08]
Raabe V and Koehler J. Laboratory diagnosis of Lassa fever. J Clin Microbiol. 2017; 55:1629–1637.
Atkin S, Anaraki S, Gothard P, Walsh A, Brown D, Gopal R, Hand J, Morgan D. The first case of Lassa fever imported from Mali to the United Kingdom. Euro Surveill 2009; 14(10):19145.
Kyei NNA, Abilba MM, Kwawu FK, Agbenohevi PG, Bonney JHK, Agbemaple TK, Nimo-Paintsil SC, Ampofo W, Ohehe S, Nyarko, EO. Imported Lassa fever: a report of 2 cases in Ghana. BMC Infect Dis. 2015; 15:217.
Gunther, S., Emmerich, P., Laue, T., Kuhle, O., Asper, M., Jung, A., Grewing, T., Meulen, J., Schmitz, H. Imported Lassa fever in Germany: molecular characterization of a new Lassa virus strain. Emergency. Infectious Diseases. 2000; 6:466–476.
Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Sci. 1974; 185:263–271.
Lecompte E, Fichet-Calvet E, Daffis S, Koulémou K, Sylla O, Kourouma F, Doré A, Soropogui B, Aniskin V, Allali B, Kouassi Kan S, Lalis A, Koivogui L, Günther S, Denys C, ter Meulen J. Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis. 2006; 12:1971–1974.
World Health Organization (WHO). Lassa fever- Nigeria, Disease outbreak news. 2019; Available from: http://www.who.int. [cited 2019 Nov 14].
McCormick JB, King IJ, Webb PA, Johnson KM, O’Sullivan R, Smith ES, Trippel S, Tong TC. A case- control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987; 155:445-455.
Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ 1988; 297:584-587.
McCarthy M. USA moves quickly to push biodefence research. Lancet 2002; 360:732.
Richmond JK and Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ 2003; 327:1271–1275.
Woyessa AB, Maximore L, Keller D, Dogba J, Pajibo M, Johnson K, Saydee E, Monday J, Tuopileyi R 2nd, Mahmoud N. Lesson learned from the investigation and response of Lassa fever outbreak, Margibi County, Liberia, 2018: case report. BMC Infect Dis. 2019; 19(1):610.
Asogun DA, Günther S, Akpede GO, Ihekweazu C, Zumla A. Lassa fever: Epidemiology, Clinical Features, Diagnosis, Management and Prevention. Infect Dis Clin North Am. 2019; 33(4):933-951.
Nigerian Centre for Disease Control (NCDC). An outbreak of Lassa fever in Nigeria, week 50. 2019; Available from: http://ncdc.gov.ng/disease. [cited 2019 Dec. 28].
Asogun DA, Donatus IA, Jacqueline E, Ikponmwonsa O, Meike H, Martin G, Stephan O, Becker ZB, Onikepe F, Eric P, Philomena EE, Veritas EI, Eghosasere AU, Yemisi TO, Ekene BM, Osagie OO, Sylvanus AO, Mojeed M, Sylvester OA, Odigie CA, Peter I, Maxy AC, Odike SG, Kristian A, Pardis CS, Christian TH, George OA, Stephen G. Molecular diagnostic for Lassa fever at Irrua specialist teaching hospital, Nigeria: Lessons learnt from two years of laboratory operation. Plos Negl Trop Dis. 2012; 6(9):1839.
McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986; 314:20 –26.
Nnennaya AA, Chinedu GN, Ben NA, Benson NO and Elizabeth U. Containing a Lassa fever epidemic in a resource-limited setting: Outbreak description and lessons learned from Abakaliki, Nigeria. Int J Infect Dis. 2013; 17(11):1011-1016.
Reuben CR and Gyar SD. Knowledge, attitudes and practices of Lassa fever in and around Lafia, Central Nigeria. Int J Pub Health Epidemiol Res. 2016; 2:14-19.
Ndu AC, Kassy WC, Ochie CN, Arinze-Onyia SU, Okeke TA, Aguwa EN, Okwor TJ, Chinawa A. Knowledge, Misperceptions, Preparedness, and Barriers towards Lassa Fever Control among Health Care Workers in a Tertiary Institution in Enugu, Nigeria. J HealthCare Poor Underserved. 2019; 30(3):1151-1164.
National Population Commission (NPC). Population and Housing Census Facts and Figures 2006. Available from: http://www.population.gov.ng/factssandfigures [cited on 2008 Nov 06].
Cochran WG. Sampling technique (3rd ed.) New York: John Wiley and Sons, 1977.
Nwonwu EU, Alo C, Una AF, Madubueze UC, Eze I, Ogbonnaya LU, Akamike IC. Knowledge of Lassa fever and its determinants among traders in Izzi community in South East Nigeria. Arch Curr Res Int. 2018; 13(4):1-9.
Ekanem AM, Mbaba EM, Monday HA, Ekwere TA, Akwaowo CD, Akpaneko EI, Umoh JS and Akwaowo, U. S. Knowledge and prevention of Lassa fever among adults in a rural community in Southern Nigeria. J Med Per. 2018; 3(7):395-399.
Bausch DG, Hadi CM, Khan SH, Lertora JJ. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis. 2010; 51:1435–1441.